Biotech ETFs Look Promising as White House May Help FDA Expedite Drug Approvals

After stumbling in 2016, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets, is bouncing back nicely in 2017 and that is a theme some market observers believe is durable. Other biotech ETFs are on the mend, too. After struggling through...